Safety of biologics in patients with autoimmune rheumatic diseases during pregnancy: Systematic review and meta-analysis
- 6 May 2025
- journal article
- review article
- Published by Elsevier in Autoimmunity Reviews
- Vol. 24 (8) , 103827
Abstract
No abstract availableKeywords
Funding Information
- Chengdu Science and Technology Bureau (2024-YF05-01180-SN)
- National Natural Science Foundation of China (82101163)
This publication has 66 references indexed in Scilit:
- Exposure to golimumab during pregnancy: Results from the Company's global safety databasePharmacology Research & Perspectives, 2024
- Pharmacokinetics of Monoclonal Antibodies Throughout Pregnancy: A Systematic Literature ReviewClinical Pharmacokinetics, 2024
- Physiologically‐Based Pharmacokinetic Modeling of Anti‐Tumor Necrosis Factor Agents for Inflammatory Bowel Disease Patients to Predict the Withdrawal Time in Pregnancy and Vaccine Time in InfantsClinical Pharmacology & Therapeutics, 2023
- Fetal and Neonatal Adverse Drug Reactions Associated with Biologics Taken During Pregnancy by Women with Autoimmune Diseases: Insights from an Analysis of the World Health Organization Pharmacovigilance Database (VigiBase®)BioDrugs, 2022
- Pregnant women with immune mediated inflammatory diseases who discontinue biologics have higher rates of disease flareArchives of Gynecology and Obstetrics, 2022
- 2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid ArthritisArthritis & Rheumatology, 2021
- Effect of biologic disease-modifying anti-rheumatic drugs for patients with rheumatoid arthritis who hope to become mothersClinical Rheumatology, 2019
- Serious Infections in Rheumatoid Arthritis Offspring Exposed to Tumor Necrosis Factor InhibitorsArthritis & Rheumatology, 2018
- Pregnancy Outcomes After Exposure to Certolizumab PegolArthritis & Rheumatology, 2018
- Pregnancy and infant outcomes including major congenital malformations among women with chronic inflammatory arthritis or psoriasis, with and without etanercept usePharmacoepidemiology and Drug Safety, 2017